MEDIKAMENTENVERABREICHUNGSVORRICHTUNG

Patent europeic · EP3914321 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3914321
Numer da la dumonda
EP20700841
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
22-01-2020
Publitgà
01-12-2021
Concedì
21-08-2024
La protecziun finescha il pli tard
21-01-2040
Proxima taxa annuala scadenta
31-01-2027
Classas IPC
A61M 5/20 (2006.01)
A61M 5/315 (2006.01)
A61M 5/31 (2006.01)
Prioritad
EP 19305091 24.01.2019
Dumonda PCT
PCT/EP2020/051454 22.01.2020
Publicaziun PCT
WO2020/152192 30.07.2020
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-02-2026

    Midada

    Published in Swissreg on 01.02.2026

  2. 02-07-2025

    Midada

    Published in Swissreg on 02.07.2025

  3. 01-02-2025

    Midada

    Published in Swissreg on 01.02.2025

  4. 21-08-2024

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 21.08.2024

Partidas

Possessur

SANOFI

Sanofi

46 avenue de la Grande Armée, 75017 Paris, FR

Inventur

BLANCKE, Stefan

65926 Frankfurt am Main, DE

MORRIS, Anthony Paul

Warwick, Warwickshire CV34 4AB, GB

JUGL, Michael

65926 Frankfurt am Main, DE

STEEL, Samuel

Warwick, Warwickshire CV34 4AB, GB

JONES, Matthew Meredith

Warwick, Warwickshire CV34 4AB, GB

MARSH, William Geoffrey Arthur

Warwick, Warwickshire CV34 4AB, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.